Clinical Trial Update: Gene Therapy for Gyrate Atrophy [Phase 1]

View source ↗

Summary

This clinical trial update reports that a Phase 1 gene therapy trial for gyrate atrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gyrate Atrophy

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Gyrate Atrophy | Phase 1 | Status: COMPLETED